Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

NVCTNVCT
10 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in NUVECTIS PHARMA INC

Yes. Charles Schwab Investment Management holds 57,133 shares of NVCT (Nuvectis Pharma), worth $1.1M, as of its Q2 2026 13F filing. It increased the position by 7,488 shares (+15.1%) from Q1 2026. Charles Schwab Investment Management has held NVCT since Q2 2025, across 5 quarterly 13F filings.

Current Value

$1.1M

Current Shares

57,133

Total Value Change

+$763,296

Total Shares Change

+39,138

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
57,133
+15.1%
$1.1M0.0%$18.39
29
2026-Q1
Increased
49,645
+12.8%
$383,7560.0%$7.73
27
2025-Q4
Increased
44,022
+15.9%
$332,3660.0%$7.55
27
2025-Q3
Unchanged
37,982
0.0%
$228,6520.0%$6.02
0
2025-Q2
New
37,982
-
$283,7260.0%$7.47
36
2024-Q2
Exited
0
-100.0%
$00.0%$6.33
0
2024-Q1
Unchanged
19,920
0.0%
$163,3440.0%$8.20
0
2023-Q4
Unchanged
19,920
0.0%
$166,1330.0%$8.34
0
2023-Q3
Increased
19,920
+10.7%
$256,7690.0%$12.89
26
2023-Q2
New
17,995
-
$287,3800.0%$15.97
32

Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used